Andrew Berens
Stock Analyst at Leerink Partners
(4.89)
# 311
Out of 5,125 analysts
561
Total ratings
46.2%
Success rate
23.7%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DMRA Damora Therapeutics | Reiterated: Buy | $51 | $24.15 | +111.18% | 3 | Nov 5, 2026 | |
| EXEL Exelixis | Reiterated: Hold | $52 → $58 | $70.58 | -17.82% | 14 | Nov 5, 2026 | |
| INCY Incyte | Reiterated: Buy | $155 → $150 | $120.30 | +24.69% | 63 | Nov 5, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $30 | $7.40 | +305.41% | 1 | Oct 20, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $40 | $14.24 | +180.90% | 1 | Sep 21, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Rated: Buy | $27 → $25 | $2.20 | +1,036.36% | 5 | Sep 18, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $0.838 | +735.32% | 26 | Aug 7, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Buy | n/a | $31.76 | - | 52 | Jul 7, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $40 | $30.02 | +33.24% | 1 | Jul 6, 2026 | |
| AURA Aura Biosciences | Reiterated: Buy | n/a | $7.65 | - | 28 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $33 | $18.65 | +76.94% | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 → $43 | $10.17 | +322.81% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $55 | $24.30 | +126.34% | 26 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $9.96 | +130.92% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $4.27 | +87.35% | 1 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $40 | $31.46 | +27.15% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $97 | $67.05 | +44.67% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $31.64 | n/a | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $3.85 | n/a | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $33 | $31.75 | n/a | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.23 | n/a | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $3.39 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $19.94 | n/a | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $2.45 | n/a | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $6.92 | n/a | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $424.00 | n/a | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $1.80 | n/a | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18.00 | $6.56 | n/a | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $0.38 | - | n/a | 25 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $155.35 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $76.81 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 → $25 | $3.00 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $15 | $10.50 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.82 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $8.14 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $113.95 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $8 | $6.61 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.5418 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.31 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $41.70 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.22 | n/a | 2 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $170.87 | n/a | 3 | Dec 1, 2014 |
Damora Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $51
Current: $24.15
Upside: +111.18%
Exelixis
Nov 5, 2026
Reiterated: Hold
Price Target: $52 → $58
Current: $70.58
Upside: -17.82%
Incyte
Nov 5, 2026
Reiterated: Buy
Price Target: $155 → $150
Current: $120.30
Upside: +24.69%
Kazia Therapeutics
Oct 20, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $7.40
Upside: +305.41%
BlossomHill Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $40
Current: $14.24
Upside: +180.90%
BridgeBio Oncology Therapeutics
Sep 18, 2026
Rated: Buy
Price Target: $27 → $25
Current: $2.20
Upside: +1,036.36%
Compass Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $0.838
Upside: +735.32%
Agios Pharmaceuticals
Jul 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.76
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $30.02
Upside: +33.24%
Aura Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.65
Upside: -
May 15, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $18.65
Upside: +76.94%
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $10.17
Upside: +322.81%
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $24.30
Upside: +126.34%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $9.96
Upside: +130.92%
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $4.27
Upside: +87.35%
Nov 19, 2025
Reiterated: Buy
Price Target: $24 → $40
Current: $31.46
Upside: +27.15%
Nov 17, 2025
Reiterated: Buy
Price Target: $70 → $97
Current: $67.05
Upside: +44.67%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $31.64
Upside: n/a
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $3.85
Upside: n/a
Oct 21, 2025
Reiterated: Hold
Price Target: $30 → $33
Current: $31.75
Upside: n/a
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $11.23
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $33
Current: $3.39
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $19.94
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: $3
Current: $2.45
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $9
Current: $6.92
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $424.00
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $1.80
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $18.00
Current: $6.56
Upside: n/a
Jun 11, 2025
Reiterated: Hold
Price Target: $1 → $0.38
Current: -
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $155.35
Upside: n/a
Dec 10, 2024
Reiterated: Buy
Price Target: n/a
Current: $76.81
Upside: n/a
Feb 7, 2023
Reiterated: Buy
Price Target: $67 → $25
Current: $3.00
Upside: n/a
Feb 7, 2023
Reiterated: Hold
Price Target: $20 → $15
Current: $10.50
Upside: n/a
Mar 21, 2022
Reiterated: Buy
Price Target: n/a
Current: $14.82
Upside: n/a
May 7, 2021
Reiterated: Hold
Price Target: $10
Current: $8.14
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Reiterated: Hold
Price Target: $23
Current: $113.95
Upside: n/a
Jul 14, 2017
Reiterated: Hold
Price Target: $16 → $8
Current: $6.61
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $0.5418
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $7.31
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $41.70
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $11.22
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $170.87
Upside: n/a